Latest News

Advion’s parent company Bohui Innovation Biotechnology will acquire Interchim group



Advion Inc. today announces parent company Beijing Bohui Innovation Biotechnology Co., Ltd., has filed its intention to acquire Adchim SAS, the parent company of the Interchim group companies.

Source link

Related posts

FDA and CBP collaborate to protect public health and safety

Newsemia

OncoImmunity erhält 2,2 Mio. Euro zur Einführung seiner Maschinenlernplattform für die Entwicklung von personalisierten Krebsimmuntherapien

Newsemia

Benzodiazepine Receptor Agonist – Pipeline Insight, 2019 – ResearchAndMarkets.com

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World